Search
Descriptor English: Biguanides
Descriptor Spanish: Biguanidas
Descriptor biguanidas
Entry term(s) biguanida
Scope note: Derivados de biguanida (fórmula estructural HN(C(NH)NH2)2) que se usan principalmente como HIPOGLUCEMIANTES orales en el tratamiento de la DIABETES MELLITUS TIPO 2 y en la PREDIABETES.
Descriptor Portuguese: Biguanidas
Descriptor French: Biguanides
Entry term(s): Biguanide
Tree number(s): D02.078.370.141
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D001645
Scope note: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Hypoglycemic Agents
Public MeSH Note: 66
History Note: 66(65)
DeCS ID: 1670
Unique ID: D001645
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/05/27
Biguanides - Preferred
Concept UI M0002471
Scope note Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
Preferred term Biguanides
Entry term(s) Biguanide



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey